These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 35483)
21. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists. Froimowitz M; Cody V Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550 [TBL] [Abstract][Full Text] [Related]
22. [Ataractic treatment in psychiatry and general medicine. Drug overview 10]. Hertrich O Fortschr Med; 1983 Nov; 101(43):1974-6. PubMed ID: 6140214 [No Abstract] [Full Text] [Related]
23. Melperone-an atypical neuroleptic. Proceedings of a workshop. Malmö, Sweden, October 8, 1986. Acta Psychiatr Scand Suppl; 1989; 352():1-50. PubMed ID: 2573236 [No Abstract] [Full Text] [Related]
24. A double-blind study of melperone and placebo in hospitalized chronic alcoholics in postintoxication phase. Carlsson C; Gullberg B; Höstery U; Christensson E Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):341-5. PubMed ID: 39900 [TBL] [Abstract][Full Text] [Related]
25. [Blood serum cobalt-activated acyltransferase in patients treated with psychotropic drugs]. Modrzewska R; Rzeszowska G; Olajossy M; Radomińska I Pol Tyg Lek; 1980 Jul; 35(28):1071-3. PubMed ID: 6107899 [No Abstract] [Full Text] [Related]
26. Epidemiology, etiology, diagnosis, and treatment of schizophrenia. Ryan PM Am J Hosp Pharm; 1991 Jun; 48(6):1271-80. PubMed ID: 1677528 [TBL] [Abstract][Full Text] [Related]
27. [Drug interferences and incompatibilities of substances affecting the central nervous system. 4. Neuroleptics]. Estler CJ Fortschr Med; 1973 Jun; 91(18):788-90. PubMed ID: 4146746 [No Abstract] [Full Text] [Related]
28. Present controversies in the treatment of schizophrenia. Kalinowsky LB Proc Rudolf Virchow Med Soc City N Y; 1972-1973; 29():121-2. PubMed ID: 4155076 [No Abstract] [Full Text] [Related]
29. [Pipamperone and the treatment of impulsive aggressive behaviour]. Klaassen AA Tijdschr Psychiatr; 2008; 50(3):179-83. PubMed ID: 18324605 [TBL] [Abstract][Full Text] [Related]
31. Use of atypical antipsychotic agents for symptom control in patients with advanced cancer. Fisch MJ; Kim HF J Support Oncol; 2004; 2(5):447-52. PubMed ID: 15524076 [No Abstract] [Full Text] [Related]
32. Hypothermia induced by atypical neuroleptics. Schwaninger M; Weisbrod M; Schwab S; Schröder M; Hacke W Clin Neuropharmacol; 1998; 21(6):344-6. PubMed ID: 9844790 [TBL] [Abstract][Full Text] [Related]
33. [Antipsychotic agents and weight gain]. Raaska K Duodecim; 2002; 118(2):157-62. PubMed ID: 12229110 [No Abstract] [Full Text] [Related]
34. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study]. Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804 [No Abstract] [Full Text] [Related]
35. [Antipsychotic agents are best chosen by their adverse effect profile]. Msghina M; Lindefors N Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2841-2, 2844-6. PubMed ID: 19967963 [No Abstract] [Full Text] [Related]
37. [Problems on FDA phase IV drug evaluation of antipsychotic agents]. Kazematsuri G Seishin Shinkeigaku Zasshi; 1990; 92(9):592-6. PubMed ID: 1980370 [No Abstract] [Full Text] [Related]
38. Do atypical antipsychotic agents cause tardive dyskinesia? Bailey KP J Psychosoc Nurs Ment Health Serv; 2004 Oct; 42(10):14-9. PubMed ID: 15540874 [No Abstract] [Full Text] [Related]